John Paulson’s portfolio: Paulson & Co 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026

Q4 2016 filing in brief

In its Q4 2016 13F, filed February 14, 2017, Paulson & Co reported $7.9B across 102 US positions. The largest: MYLAN N V (9.9%), ALLERGAN PLC (9.4%), SHIRE PLC (9.0%), TEVA (7.3%), GLD (6.0%). In the quarter it opened 26 positions, sold out of 18, added to 11 and trimmed 28; positions opened and sold out came to 11.9% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 14, 2017

  • 26 New
  • 11 Added
  • 28 Trimmed
  • 18 Exited

102 positions at December 31, 2016. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1—MYLAN N V$786M20.6M9.91%−5.5%Trimmed
2—ALLERGAN PLC$747M3.6M9.41%−8.6%Trimmed
3—SHIRE PLC$717M4.2M9.03%−9.9%Trimmed
4TEVATEVA PHARMACEUTICAL INDS LTD$577M15.9M7.28%−0.9%Held
5GLDSPDR GOLD TRUST$478M4.4M6.02%−8.7%Trimmed
6STAYUSDEXTENDED STAY AMER INC$455M28.6M5.74%−24.0%Trimmed
7—MALLINCKRODT PUB LTD CO$397M8.0M5.01%0.0%Held
8AIGAMERICAN INTL GROUP INC$314M4.8M3.96%−46.9%Trimmed
9—VALEANT PHARMACEUTICALS INTL$281M19.4M3.55%+2.7%Added
10TWXCHFTIME WARNER INC$276M2.9M3.47%—New
11AKRXEURAKORN INC$190M8.7M2.39%−3.2%Trimmed
12—CAESARS ACQUISITION CO$177M13.1M2.23%0.0%Held
13—SYNERGY PHARMACEUTICALS DEL$147M24.1M1.85%−0.6%Held
14AU3EURANGLOGOLD ASHANTI LTD$134M12.8M1.69%0.0%Held
15—ENDO INTL PLC$129M7.8M1.63%−1.4%Trimmed
16—REALOGY HLDGS CORP$123M4.8M1.55%0.0%Held
17CZRCAESARS ENTMT CORP$123M14.4M1.54%0.0%Held
18NGNOVAGOLD RES INC$102M22.3M1.28%−13.0%Trimmed
19—HARMAN INTL INDS INC$95M853.8K1.20%—New
20—B/E AEROSPACE INC$79M1.3M1.00%—New
21OASEUROASIS PETE INC NEW$79M5.2M0.99%−0.4%Held
22VMWEURVMWARE INC$78M992.2K0.98%−48.2%Trimmed
23ODPEUROFFICE DEPOT INC$69M15.3M0.87%−0.7%Held
24HPEHEWLETT PACKARD ENTERPRISE C$69M3.0M0.87%−50.1%Trimmed
25TSUTIM PARTICIPACOES S A$67M5.7M0.84%−0.8%Held
26WLHUSDLYON WILLIAM HOMES$63M3.3M0.80%0.0%Held
27—BANK OF AMERICA CORPORATION$62M6.3M0.79%−51.5%Trimmed
28CIEI 3.125 05/15/24COBALT INTL ENERGY INC$61M219.2M0.77%0.0%Held
29—DELL TECHNOLOGIES INC$60M1.1M0.76%−0.6%Held
30—INTERNATIONAL SEAWAYS INC$52M3.7M0.65%—New
31TTWOTAKE-TWO INTERACTIVE SOFTWAR$48M967.9K0.60%−0.6%Held
32AEMAGNICO EAGLE MINES LTD$45M1.1M0.57%−14.3%Trimmed
33—ALLERGAN PLCcall option$45M214.7K0.57%0.0%Held
34—RANDGOLD RES LTD$38M500.0K0.48%0.0%Held
35—COBALT INTL ENERGY INC$38M31.1M0.48%−0.3%Held
36—WHITEWAVE FOODS CO$38M676.4K0.47%—New
37—NXP SEMICONDUCTORS N V$37M373.0K0.46%—New
38ATVIEURACTIVISION BLIZZARD INC$35M968.0K0.44%−0.6%Held
39—MYLAN N Vcall option$34M904.2K0.43%−3.8%Trimmed
40THMINTERNATIONAL TOWER HILL MIN$31M55.5M0.39%+140.6%Added
41—ENZYMOTEC LTD$28M4.2M0.35%0.0%Held
42—SHIRE PLCcall option$27M160.0K0.34%+166.7%Added
43—LOXO ONCOLOGY INC$27M828.6K0.34%+12.4%Added
44ALXNALEXION PHARMACEUTICALS INCcall option$24M200.0K0.31%—New
45—STERIS PLC$21M313.5K0.27%+0.5%Held
46METAFACEBOOK INC$21M181.0K0.26%−14.9%Trimmed
47ALXNALEXION PHARMACEUTICALS INC$19M153.3K0.24%−32.7%Trimmed
48ALXNALEXION PHARMACEUTICALS INCput option$19M153.0K0.24%—New
49EBAYEBAY INC$18M622.6K0.23%−0.9%Held
50CIEI 2.625 12/01/19COBALT INTL ENERGY INC$18M45.3M0.22%−6.2%Trimmed
51TIME1EURTIME INC NEW$18M992.2K0.22%—New
52DXCMDEXCOM INC$18M293.2K0.22%+574.0%Added
53WENWENDYS COput option$17M1.3M0.21%—New
54GOOGALPHABET INC$17M21.7K0.21%—New
55—AMERICAN CAP LTD$16M865.9K0.20%−80.0%Trimmed
56ETSYETSY INC$15M1.3M0.19%+1.0%Held
57IAGIAMGOLD CORP$15M3.9M0.19%0.0%Held
58BIIBBIOGEN INC$15M52.2K0.19%−83.1%Trimmed
59—LIVANOVA PLC$14M310.0K0.18%+11.9%Added
60—PANDORA MEDIA INCput option$13M990.0K0.16%—New
61WDAYWORKDAY INC$11M173.9K0.14%—New
62PFEPFIZER INC$11M352.2K0.14%+39.8%Added
63—GLAXOSMITHKLINE PLC$11M296.0K0.14%—New
64SNYSANOFI$10M253.0K0.13%−39.3%Trimmed
65COR1EURCORESITE RLTY CORP$10M128.2K0.13%—New
66—SYNTHESIS ENERGY SYS INC$10M10.0M0.13%0.0%Held
67SD 0 10/04/20SANDRIDGE ENERGY INC$10M7.9M0.13%—New
68CYHCOMMUNITY HEALTH SYS INC NEWput option$9M1.6M0.11%+25.5%Added
69—BANK OF AMERICA CORPORATION$9M8.9M0.11%−0.2%Held
70HCAHCA HOLDINGS INC$8M111.6K0.10%−31.3%Trimmed
71—NEUSTAR INC$7M200.0K0.08%—New
72ISRGINTUITIVE SURGICAL INC$6M10.1K0.08%—New
73BSXBOSTON SCIENTIFIC CORP$6M288.0K0.08%−29.8%Trimmed
74MELIMERCADOLIBRE INC$6M38.4K0.08%+83.7%Added
75—REYNOLDS AMERICAN INC$6M106.0K0.07%—New
76TMQTRILOGY METALS INC NEW$6M11.6M0.07%−0.1%Held
77SDSANDRIDGE ENERGY INC$6M245.0K0.07%—New
78—FELCOR LODGING TR INC$4M500.0K0.05%0.0%Held
79—KAMADA LTD$4M730.8K0.05%0.0%Held
80GPROGOPRO INCput option$3M400.0K0.04%—New
81CBOECBOE HLDGS INC$3M38.4K0.04%0.0%Held
82INSMINSMED INC$3M205.2K0.03%0.0%Held
83BCRXBIOCRYST PHARMACEUTICALScall option$2M350.0K0.03%—New
84DGDOLLAR GEN CORP NEW$2M29.6K0.03%—New
85—MEAD JOHNSON NUTRITION CO$2M30.8K0.03%−60.8%Trimmed
86FDXFEDEX CORP$2M11.0K0.03%−89.7%Trimmed
87SHOPSHOPIFY INC$2M40.7K0.02%−45.1%Trimmed
88—WCI CMNTYS INC$2M70.0K0.02%0.0%Held
89ALDR1EURALDER BIOPHARMACEUTICALS INC$2M74.0K0.02%0.0%Held
90—ESPERION THERAPEUTICS INC NE$1M102.0K0.02%0.0%Held
91RTRXEURRETROPHIN INC$1M55.0K0.01%—New
92AKAOQACHAOGEN INC$944K72.5K0.01%—New
93RIGLRIGEL PHARMACEUTICALS INC$923K387.7K0.01%−51.8%Trimmed
94ALNYALNYLAM PHARMACEUTICALS INC$723K19.3K0.01%0.0%Held
95DVAXDYNAVAX TECHNOLOGIES CORP$687K174.0K0.01%0.0%Held
96PBYIPUMA BIOTECHNOLOGY INC$482K15.7K0.01%−81.4%Trimmed
97BCRXBIOCRYST PHARMACEUTICALS$333K52.6K0.00%−85.5%Trimmed
98ARDMEURARADIGM CORP$308K192.7K0.00%+31.2%Added
99OSG1EUROVERSEAS SHIPHOLDING GROUP I$274K71.6K0.00%+58.6%Added
100—CELLDEX THERAPEUTICS INC NEW$251K70.8K0.00%0.0%Held
101—LIBERTY GLOBAL PLC$110K5.0K0.00%0.0%Held
102—NOVADAQ TECHNOLOGIES INCput option$25K500.0K0.00%—New
18 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
TMUST-MOBILE US INC$45M954.0K
—TOBIRA THERAPEUTICS INC$43M1.1M
GRFSGRIFOLS SA-ADR$40M2.5M
VNDAVANDA PHARMACEUTICALS INC$36M2.2M
HUMHUMANA INC$14M79.5K
MARMARRIOTT INTERNATIONAL -CL A$11M170.0K
MCKMCKESSON CORP$11M67.0K
CVSCVS HEALTH CORP$11M122.2K
—ST JUDE MEDICAL INC$8M94.5K
EXPEEXPEDIA INC$7M63.3K
—MONSTER WORLDWIDE INC$7M2.0M
—INFOBLOX INC$6M230.0K
—INGRAM MICRO INC-CL A$5M145.1K
JNJJOHNSON & JOHNSON$4M35.0K
—ITC HOLDINGS CORP$4M85.1K
—CARMIKE CINEMAS INC$4M120.0K
LLYELI LILLY & CO$4M45.8K
TLNDTALEND SA - ADR$3M100.8K
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.